| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |